FVTI 最新10-Q变化
将 FVTI 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2024-08-14 与上一份 10-Q · 2024-05-20
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +14 | −7 | ~10 | 9 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 10 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2024-08-14
Net loss attributable to noncontrolling interests (49,796) (58,361) 8,565
Net revenues were $247,061 for the three months ended June 30, 2024, reflecting a decrease of $1,025,536, or 81%, from $1,272,597 for the three months ended June 30, 2023. The decrease in net revenues was mainly due to the lower product sales volume than the same period of the prior year and to a le…
Net revenues were $514,883 for the six months ended June 30, 2024, reflecting a decrease of $2,393,003, or 82%, from $2,907,886 for the six months ended June 30, 2023. The decrease in net revenues was mainly due to the lower product sales volume than the same period of the prior year and to a lesser…
Cost of revenues was $202,785 for the three months ended June 30, 2024, reflecting a decrease of $450,13, or 69%, from $652,798 for the three months ended June 30, 2023. The decrease in cost of revenues was mainly due to the lower product sales volume in line with our net revenues decrease and to a …
Cost of revenues was $415,674 for the six months ended June 30, 2024, reflecting a decrease of $914,491, or 69%, from $1,330,165 for the six months ended June 30, 2023. The decrease in cost of revenues was mainly due to the lower product sales volume in line with our net revenues decrease and to a l…
相对上期删除的文字 · 来源:10-Q · 2024-05-20
Net revenues were $267,822 for the three months ended March 31, 2024, reflecting a decrease of $1,367,467, or 84%, from $1,635,289 for the three months ended March 31, 2023. The decrease in net revenues was mainly due to the lower product sales volume than the same period of the prior year and to a …
Cost of revenues was $212,889 for the three months ended March 31, 2024, reflecting a decrease of $464,478, or 69%, from $677,367 for the three months ended March 31, 2023. The decrease in cost of revenues was mainly due to the lower product sales volume in line with our net revenues decrease and to…
Gross profit was $54,933 and $957,922 for the three months ended March 31, 2024 and 2023, respectively, reflecting a decrease of $902,989, or 94%. The decrease in gross profit was mainly due to the decrease in the net revenues.
Operating expenses were $1,047,874 for the three months ended March 31, 2024, reflecting an increase of $83,237, or 9%, from $964,637 for the three months ended March 31, 2023. The increase in operating expenses was mainly due to the allowance of credit loss for accounts receivable.
For the three months ended March 31, 2024, our net loss was $1,001,080, compared to the net loss of $89,176 for the three months ended March 31, 2023. The increase in net loss was a result of the factors described above.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议